Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Réglementation et droit · 20/12/20131 min de lecture
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Antibody-Dependent Cellular Cytoxicity (ADCC)-Mediating Antibodies
Traduction automatique locale · Langue originale de la source
Résumé
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/762,543, entitled "Antibody-Dependent Cellular Cytoxicity (ADCC)- Mediating Antibodies," filed on February 8, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Langue originale de la source: Federal Register — All DocumentsOuvrir le communiqué original →